Cargando…

Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome

Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite trimethylamine (TMA), has been identified to be an independent risk factor for promoting atherosclerosis. Evidences suggest that berberine (BBR) could be used to treat obesity, diabetes and atherosclerosis, however, its m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xingxing, Su, Chunyan, Jiang, Zhibo, Yang, Yuxin, Zhang, Yue, Yang, Mengxia, Zhang, Xiumin, Du, Yu, Zhang, Jin, Wang, Li, Jiang, Jiandong, Hong, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052457/ https://www.ncbi.nlm.nih.gov/pubmed/33863898 http://dx.doi.org/10.1038/s41522-021-00205-8

Ejemplares similares

Gut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
por: Zhu, Yingqian, et al.
Publicado: (2020)

The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease
por: El Hage, Racha, et al.
Publicado: (2023)

Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
por: Wang, BingYu, et al.
Publicado: (2021)

Bifidobacterium breve and Bifidobacterium longum Attenuate Choline-Induced Plasma Trimethylamine N-Oxide Production by Modulating Gut Microbiota in Mice
por: Wang, Qianqian, et al.
Publicado: (2022)

Residual Risk of Trimethylamine‐N‐Oxide and Choline for Stroke Recurrence in Patients With Intensive Secondary Therapy
por: Xue, Jing, et al.
Publicado: (2022)

Oxidation of trimethylamine to trimethylamine N-oxide facilitates high hydrostatic pressure tolerance in a generalist bacterial lineage
por: Qin, Qi-Long, et al.
Publicado: (2021)

Simultaneous quantification of trimethylamine N-oxide, trimethylamine, choline, betaine, creatinine, and propionyl-, acetyl-, and l-carnitine in clinical and food samples using HILIC-LC-MS
por: Hefni, Mohammed E, et al.
Publicado: (2021)

Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism
por: Ding, Lin, et al.
Publicado: (2018)

Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
por: Jing, Lele, et al.
Publicado: (2022)

Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-N-Oxide Response in Healthy Men
por: Cho, Clara E., et al.
Publicado: (2020)

β-sitosterol inhibits trimethylamine production by regulating the gut microbiota and attenuates atherosclerosis in ApoE(–/–) mice
por: Wu, Weiping, et al.
Publicado: (2022)

Metformin decreases bacterial trimethylamine production and trimethylamine N-oxide levels in db/db mice
por: Kuka, Janis, et al.
Publicado: (2020)

Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
por: Chen, Ming-liang, et al.
Publicado: (2016)

Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease
por: Fennema, Diede, et al.
Publicado: (2016)

Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans
por: Randrianarisoa, Elko, et al.
Publicado: (2016)

Trimethylamine-N-Oxide Levels Are Similar in Asymptomatic vs. Symptomatic Cerebrovascular Atherosclerosis
por: Heyse, Miriam, et al.
Publicado: (2021)

Experimental Periodontitis Deteriorated Atherosclerosis Associated With Trimethylamine N-Oxide Metabolism in Mice
por: Xiao, Lingling, et al.
Publicado: (2022)

Simultaneous Measurement of Urinary Trimethylamine (TMA) and Trimethylamine N-Oxide (TMAO) by Liquid Chromatography–Mass Spectrometry
por: Jia, Xun, et al.
Publicado: (2020)

Higher Trimethylamine-N-Oxide Plasma Levels with Increasing Age Are Mediated by Diet and Trimethylamine-Forming Bacteria
por: Rath, Silke, et al.
Publicado: (2021)

Trimethylamine N-Oxide in Heart Failure: A Meta-Analysis of Prognostic Value
por: Li, Xingxing, et al.
Publicado: (2022)

Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation
por: Panyod, Suraphan, et al.
Publicado: (2022)

Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis
por: Cai, Yuan-Yuan, et al.
Publicado: (2022)

Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide
por: Romano, Kymberleigh A., et al.
Publicado: (2015)

Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms
por: Schugar, Rebecca C, et al.
Publicado: (2022)

Association of Choline Intake with Blood Pressure and Effects of Its Microbiota-Dependent Metabolite Trimethylamine-N-Oxide on Hypertension
por: He, Guo-dong, et al.
Publicado: (2022)

Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
por: Chen, Yu-ming, et al.
Publicado: (2016)

Corrigendum: Experimental Periodontitis Deteriorated Atherosclerosis Associated With Trimethylamine N-Oxide Metabolism in Mice
por: Xiao, Lingling, et al.
Publicado: (2022)

Positive Association of Plasma Trimethylamine-N-Oxide and Atherosclerosis in Patient with Acute Coronary Syndrome
por: Kong, Wanwen, et al.
Publicado: (2022)

The Association between Trimethylamine N-Oxide and Its Predecessors Choline, L-Carnitine, and Betaine with Coronary Artery Disease and Artery Stenosis
por: Guo, Fei, et al.
Publicado: (2020)

Trimethylamine N-Oxide: The Good, the Bad and the Unknown
por: Velasquez, Manuel T., et al.
Publicado: (2016)

Trimethylamine N-oxide in atrial fibrillation progression
por: Büttner, Petra, et al.
Publicado: (2020)

Trimethylamine N-oxide (TMAO) in human health
por: Gatarek, Paulina, et al.
Publicado: (2021)

Influence of Trimethylamine N-Oxide on Platelet Activation
por: Emonds, Julian Josef, et al.
Publicado: (2022)

Associations of Circulating Levels of Trimethylamine N-oxide, Choline, Carnitine, and Betaine with Inflammatory Markers Among Breast Cancer Survivors
por: Lee, Yeon Jin, et al.
Publicado: (2022)

Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis
por: Liu, Yarong, et al.
Publicado: (2020)

The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review
por: Oktaviono, Yudi Her, et al.
Publicado: (2023)

Trimethylamine-N-oxide is an important target for heart and brain diseases
por: Ding, Shusi, et al.
Publicado: (2022)

Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice
por: Wang, Zhichao, et al.
Publicado: (2022)

Author Correction: Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis
por: Cai, Yuan-Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ihcb3km5pjsi5saacisrpcu3ar